trending Market Intelligence /marketintelligence/en/news-insights/trending/zq3fpxxv8lsntt7ozes9vq2 content esgSubNav
In This List

Sienna Biopharmaceuticals appoints CFO

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Sienna Biopharmaceuticals appoints CFO

California-based Sienna Biopharmaceuticals Inc. appointed John Smither as CFO.

Smither served as the company's CFO from January 2016 to March 2017, and subsequently served as an independent consultant in the biopharmaceutical industry.

Smither will succeed Richard Peterson, who resigned for personal reasons, effective March 29.